0.60% Nasdaq 0.07%Pulmo BioTech Inc. (PLMO.PK)
-OTC Markets 0.02 
0.00(14.29%) May 25, 10:36AM EDT
| Pulmo BioTech Inc. 1035 Park Avenue Suite 7B New York, NY 10028-0912 United States - Map Phone: 646-827-9362 Fax: 646-827-5432 Website: http://www.pulmobiotech.com
Pulmo Bio Tech Inc., through its subsidiary, PulmoScience, Inc., engages in developing a non-invasive molecular imaging technique for the diagnosis of pulmonary embolism, pulmonary hypertension, and lung inflammatory diseases under the trade name PulmoBind. The PulmoBind uses an intravenously delivered radionuclide tagged molecule, which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. It is under the regulatory approval process for Phase I human trials. The company was founded in 2006 and is based in New York, New York.
|
| ||||||||||||||||||||||||||||||||||||